Kenvue Inc. (NYSE:KVUE) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Kenvue Inc. (NYSE:KVUE) have earned an average rating of “Hold” from the fourteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $23.09.

Several equities analysts have weighed in on the company. Sanford C. Bernstein assumed coverage on Kenvue in a research note on Thursday, April 11th. They issued an “underperform” rating and a $18.00 target price on the stock. Citigroup reissued a “neutral” rating and issued a $21.00 target price on shares of Kenvue in a research note on Tuesday, May 28th. HSBC increased their target price on Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Wednesday, May 8th. Finally, William Blair assumed coverage on Kenvue in a research note on Wednesday, April 3rd. They issued a “market perform” rating on the stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Beaumont Financial Advisors LLC grew its stake in Kenvue by 3.0% in the fourth quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock valued at $377,000 after purchasing an additional 509 shares in the last quarter. Pinnacle Bancorp Inc. lifted its position in shares of Kenvue by 51.3% in the fourth quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock valued at $33,000 after buying an additional 526 shares during the last quarter. Manchester Capital Management LLC lifted its position in shares of Kenvue by 80.8% in the first quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock valued at $25,000 after buying an additional 530 shares during the last quarter. Tradition Wealth Management LLC lifted its position in shares of Kenvue by 2.8% in the fourth quarter. Tradition Wealth Management LLC now owns 21,278 shares of the company’s stock valued at $458,000 after buying an additional 575 shares during the last quarter. Finally, Dfpg Investments LLC lifted its position in shares of Kenvue by 2.3% in the fourth quarter. Dfpg Investments LLC now owns 26,659 shares of the company’s stock valued at $567,000 after buying an additional 589 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Kenvue Trading Up 1.6 %

Shares of KVUE opened at $18.24 on Wednesday. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.66. Kenvue has a 12-month low of $17.75 and a 12-month high of $26.60. The firm has a market capitalization of $34.93 billion, a PE ratio of 23.38, a price-to-earnings-growth ratio of 1.93 and a beta of 1.41. The stock’s fifty day simple moving average is $19.14 and its 200-day simple moving average is $19.93.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03. Kenvue had a return on equity of 21.06% and a net margin of 9.63%. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $3.79 billion. The business’s revenue for the quarter was down 24.9% compared to the same quarter last year. As a group, research analysts predict that Kenvue will post 1.17 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th were issued a dividend of $0.20 per share. The ex-dividend date was Tuesday, May 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.39%. Kenvue’s payout ratio is presently 102.56%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.